265 related articles for article (PubMed ID: 22832933)
1. Validation of a radiosensitivity molecular signature in breast cancer.
Eschrich SA; Fulp WJ; Pawitan Y; Foekens JA; Smid M; Martens JW; Echevarria M; Kamath V; Lee JH; Harris EE; Bergh J; Torres-Roca JF
Clin Cancer Res; 2012 Sep; 18(18):5134-43. PubMed ID: 22832933
[TBL] [Abstract][Full Text] [Related]
2. Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer.
Torres-Roca JF; Fulp WJ; Caudell JJ; Servant N; Bollet MA; van de Vijver M; Naghavi AO; Harris EE; Eschrich SA
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):631-8. PubMed ID: 26461005
[TBL] [Abstract][Full Text] [Related]
3. Using the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated With Adjuvant Radiation Therapy.
Mohammadi H; Prince A; Figura NB; Peacock JS; Fernandez DC; Montejo ME; Chon HS; Wenham RM; Eschrich SA; Torres-Roca JF; Ahmed KA
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):496-502. PubMed ID: 31759077
[TBL] [Abstract][Full Text] [Related]
4. A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset.
Jang BS; Kim IA
Radiother Oncol; 2017 Sep; 124(3):403-410. PubMed ID: 28579282
[TBL] [Abstract][Full Text] [Related]
5. A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation.
Eschrich SA; Pramana J; Zhang H; Zhao H; Boulware D; Lee JH; Bloom G; Rocha-Lima C; Kelley S; Calvin DP; Yeatman TJ; Begg AC; Torres-Roca JF
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):489-96. PubMed ID: 19735873
[TBL] [Abstract][Full Text] [Related]
6. Tumour radiosensitivity is associated with immune activation in solid tumours.
Strom T; Harrison LB; Giuliano AR; Schell MJ; Eschrich SA; Berglund A; Fulp W; Thapa R; Coppola D; Kim S; Frakes J; Foekens J; Mulé JJ; Torres-Roca JF
Eur J Cancer; 2017 Oct; 84():304-314. PubMed ID: 28863385
[TBL] [Abstract][Full Text] [Related]
7. A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway.
Meng J; Li P; Zhang Q; Yang Z; Fu S
Oncotarget; 2014 Jul; 5(13):4683-93. PubMed ID: 24970813
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors.
Sjöström M; Staaf J; Edén P; Wärnberg F; Bergh J; Malmström P; Fernö M; Niméus E; Fredriksson I
Breast Cancer Res; 2018 Jul; 20(1):64. PubMed ID: 29973242
[TBL] [Abstract][Full Text] [Related]
9. Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer.
Tanić M; Krivokuća A; Čavić M; Mladenović J; Plesinac Karapandžić V; Beck S; Radulović S; Susnjar S; Janković R
Radiat Oncol; 2018 Oct; 13(1):193. PubMed ID: 30285791
[TBL] [Abstract][Full Text] [Related]
10. The radiosensitivity index predicts for overall survival in glioblastoma.
Ahmed KA; Chinnaiyan P; Fulp WJ; Eschrich S; Torres-Roca JF; Caudell JJ
Oncotarget; 2015 Oct; 6(33):34414-22. PubMed ID: 26451615
[TBL] [Abstract][Full Text] [Related]
11. Tumor mutation burden, immune checkpoint crosstalk and radiosensitivity in single-cell RNA sequencing data of breast cancer.
Jang BS; Han W; Kim IA
Radiother Oncol; 2020 Jan; 142():202-209. PubMed ID: 31767471
[TBL] [Abstract][Full Text] [Related]
12. Development of triple-negative breast cancer radiosensitive gene signature and validation based on transcriptome analysis.
Wushou A; Jiang YZ; Hou J; Liu YR; Guo XM; Shao ZM
Breast Cancer Res Treat; 2015 Nov; 154(1):57-62. PubMed ID: 26476726
[TBL] [Abstract][Full Text] [Related]
13. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.
Scott JG; Berglund A; Schell MJ; Mihaylov I; Fulp WJ; Yue B; Welsh E; Caudell JJ; Ahmed K; Strom TS; Mellon E; Venkat P; Johnstone P; Foekens J; Lee J; Moros E; Dalton WS; Eschrich SA; McLeod H; Harrison LB; Torres-Roca JF
Lancet Oncol; 2017 Feb; 18(2):202-211. PubMed ID: 27993569
[TBL] [Abstract][Full Text] [Related]
14. Integrating Radiosensitivity and Immune Gene Signatures for Predicting Benefit of Radiotherapy in Breast Cancer.
Cui Y; Li B; Pollom EL; Horst KC; Li R
Clin Cancer Res; 2018 Oct; 24(19):4754-4762. PubMed ID: 29921729
[No Abstract] [Full Text] [Related]
15. Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer.
Strom T; Hoffe SE; Fulp W; Frakes J; Coppola D; Springett GM; Malafa MP; Harris CL; Eschrich SA; Torres-Roca JF; Shridhar R
Radiother Oncol; 2015 Oct; 117(1):159-64. PubMed ID: 26235848
[TBL] [Abstract][Full Text] [Related]
16. Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer management.
Ahmed KA; Liveringhouse CL; Mills MN; Figura NB; Grass GD; Washington IR; Harris EE; Czerniecki BJ; Blumencranz PW; Eschrich SA; Scott JG; Diaz R; Torres-Roca JF
EBioMedicine; 2019 Sep; 47():163-169. PubMed ID: 31416721
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer.
Speers C; Zhao S; Liu M; Bartelink H; Pierce LJ; Feng FY
Clin Cancer Res; 2015 Aug; 21(16):3667-77. PubMed ID: 25904749
[TBL] [Abstract][Full Text] [Related]
18. The Radiosensitivity Index Gene Signature Identifies Distinct Tumor Immune Microenvironment Characteristics Associated With Susceptibility to Radiation Therapy.
Grass GD; Alfonso JCL; Welsh E; Ahmed KA; Teer JK; Pilon-Thomas S; Harrison LB; Cleveland JL; Mulé JJ; Eschrich SA; Enderling H; Torres-Roca JF
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(3):635-647. PubMed ID: 35289298
[TBL] [Abstract][Full Text] [Related]
19. Integrating Radiosensitivity Gene Signature Improves Glioma Outcome and Radiotherapy Response Prediction.
Wu S; Xu J; Li G; Jin X
Medicina (Kaunas); 2022 Sep; 58(10):. PubMed ID: 36295489
[TBL] [Abstract][Full Text] [Related]
20. Developing a radiosensitivity gene signature for Caucasian patients with breast cancer.
Ji Y; Jiang Q; Jian G; Sun H; Wang Y; Qin H; Zhang S; Cao J; Tang Z
Oncol Rep; 2018 Sep; 40(3):1695-1705. PubMed ID: 30015959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]